Villarejo_2003_Clin.Neuropharmacol_26_119

Reference

Title : Cholinergic-dopaminergic imbalance in Pisa syndrome - Villarejo_2003_Clin.Neuropharmacol_26_119
Author(s) : Villarejo A , Camacho A , Garcia-Ramos R , Moreno T , Penas M , Juntas R , Ruiz J
Ref : Clinical Neuropharmacology , 26 :119 , 2003
Abstract :

Pisa syndrome is a rare type of truncal dystonia. Its development is associated commonly with neuroleptic treatment, but there are rare idiopathic cases or those related to neurodegenerative disorders. Recently, an association between cholinesterase inhibitors and Pisa syndrome has been described. The authors report two patients, one with Alzheimer's disease treated with risperidone and another with Parkinson's disease who presented this kind of dystonia after donepezil initiation. In the first patient the condition resolved after discontinuation of risperidone, and in the second one the condition resolved when donepezil was withdrawn. In patients with pharmacologic or degenerative dopaminergic neurotransmission disorders, cholinergic excess may induce this peculiar type of dystonia.

PubMedSearch : Villarejo_2003_Clin.Neuropharmacol_26_119
PubMedID: 12782913

Related information

Citations formats

Villarejo A, Camacho A, Garcia-Ramos R, Moreno T, Penas M, Juntas R, Ruiz J (2003)
Cholinergic-dopaminergic imbalance in Pisa syndrome
Clinical Neuropharmacology 26 :119

Villarejo A, Camacho A, Garcia-Ramos R, Moreno T, Penas M, Juntas R, Ruiz J (2003)
Clinical Neuropharmacology 26 :119